MASI

Masimo Corporation (NASDAQ:MASI) is a medical technology company founded in 1989 and headquartered in Irvine, California. The company went public in 2007 and has established itself as a leader in noninvasive patient monitoring technologies. Masimo is best known for developing Signal Extraction Technology (SET) pulse oximetry, which revolutionized patient monitoring by providing accurate readings even when patients are moving or have poor blood circulation. Over the past few years, the company has undergone significant strategic changes, including a brief diversification into consumer audio products through the acquisition of Sound United, which it later divested to refocus on its core healthcare business under new CEO Katie Szyman who joined in 2024.